Logo image
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study
Journal article   Peer reviewed

The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study

J. Frayne, S. Watson, M. Snellen, T. Nguyen and M. Galbally
Pregnancy Hypertension, Vol.24, pp.22-26
2021
url
Link to Published Version *Subscription may be requiredView

Abstract

Objectives Women with severe mental illnesses (SMI) may have elevated rates of hypertensive disorders in pregnancy (HDP) due to an accumulation of risk factors. This study aims to determine the prevalence rate of HPD within a population of women with SMI and to report on rates within different mental illness diagnoses and types of medication exposure. Study design A retrospective multicentre study of 521 pregnant women attending specialised antenatal clinics for the management of established SMI. Main outcome measures Measures included sociodemographic characteristics, pregnancy complications, mental health diagnosis and psychotropic medication use. Results Overall, 14% of women in the study had HDP. Compared to women with non-affective psychotic and other non-psychotic disorders (10.3%), women with depression and anxiety disorders demonstrated an increased risk of having a diagnosis of HDP (18.8%; RR = 1.82 [95% CI: 1.01, 3.29], p = .048). Log-binomial regression demonstrated that both a BMI in the overweight and obese range (RR = 3.37 [95% CI: 1.04, 10.95], p = .044) and continuous SNRI treatment throughout pregnancy (RR = 2.79 [95% CI; 1.33, 5.83], p = .006) were significant predictors of HDP, after adjusting for maternal age, gestational diabetes, and other mental health diagnoses. Conclusion Women with severe mental illnesses have elevated risk of developing HPD. Management remains complex and should address their comorbid risk profiles, and weigh up the risks and benefits of psychotropic medication use, given these results provide evidence of elevated rates of HDP associated with exposure to SNRI when taken throughout pregnancy.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.72 Obstetrics & Gynecology
1.72.1072 Perinatal Mental Health
Web Of Science research areas
Obstetrics & Gynecology
Peripheral Vascular Disease
ESI research areas
Clinical Medicine
Logo image